Abstract
This study was undertaken to investigate the role of two α2-macroglobulin (A2M) polymorphisms, an intronic 5-bp deletion and Ile1000Val, in the development of Alzheimer's disease (AD) and to evaluate the interaction between the apolipoprotein E (APOE) and A2M polymorphisms. The A2M polymorphisms were screened by using polymerase-chain-reaction-based assays in 555 white late-onset AD cases and 446 controls. The gentoype distributions of the 5-bp deletion and Ile1000Val polymorphisms were comparable between cases and controls (P=0.158 and P=0.148, respectively). Likewise, there was no significant difference in allele frequencies of each polymorphism among cases and controls (P=0.361 and P=0.062, respectively). The stratification of data by APOE*4 status also did not yield any significant association. In conclusion, we observed no association between either the intronic deletion polymorphism or the Ile1000Val polymorphism of A2M and AD in our case-control cohort.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Electronic Publication
Rights and permissions
About this article
Cite this article
Wang, X., Luedecking, E., Minster, R. et al. Lack of association between α2-macroglobulin polymorphisms and Alzheimer's disease. Hum Genet 108, 105–108 (2001). https://doi.org/10.1007/s004390000445
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s004390000445